tobramycin has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accurso, FJ; Ajayi, T; Barth, J; Branstrom, A; Bronsveld, I; De Boeck, K; Elborn, JS; Elfring, GL; Fajac, I; Kerem, E; Knoop, C; Konstan, MW; Malfroot, A; McColley, SA; Melotti, P; Peltz, SW; Quattrucci, S; Rietschel, E; Rosenbluth, DB; Rowe, SM; Sermet-Gaudelus, I; Spiegel, RJ; Walker, PA; Welch, EM; Wilschanski, M; Zeitlin, PL | 1 |
| Aslam, AA; Higgins, C; Sinha, IP; Southern, KW | 1 |
1 review(s) available for tobramycin and oxadiazoles
| Article | Year |
|---|---|
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Codon, Nonsense; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Middle Aged; Oxadiazoles; Quality of Life; Randomized Controlled Trials as Topic; Tobramycin | 2017 |
1 trial(s) available for tobramycin and oxadiazoles
| Article | Year |
|---|---|
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Chlorides; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Oxadiazoles; Sweat; Tobramycin; Young Adult | 2014 |